PR NEWSWIRE

Previous Stories

SOR Targets First Breath-Powered Phone Call

May 19 2026 - PR NewsWire

PERTH, Australia, May 19, 2026 /PRNewswire/ — Strategic Elements Ltd (ASX: SOR) advises that an Energy Ink™ program targeting what…


AusNet rolls out unified customer connections platform to fast-track services as grid demand rises

May 19 2026 - PR NewsWire

MELBOURNE, Australia, May 19, 2026 /PRNewswire/ — AusNet, Australia’s largest diversified energy network business, has collaborated with IBM Consulting (NYSE:…


Decision Governance to Enhance Accountability and Transparency of Decisions in Enterprises

May 19 2026 - PR NewsWire

The decision governance gap was always there. AI agents just made it impossible to ignore. MELBOURNE, Australia, May 19, 2026…


Strider Report Reveals Scale of Australian and New Zealand Academic Research Done in Collaboration with PLA-affiliated Entities on STEM Technologies

May 19 2026 - PR NewsWire

Strider identifies more than 6,000 joint publications and collaborations between researchers from 80 Australian organisations and Chinese government linked institutions…


IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

May 19 2026 - PR NewsWire

IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached with no dose-limiting toxicities observed. TLX101-Tx is also…


DAVE & BUSTER’S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION

May 19 2026 - PR NewsWire

Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights First Dave & Buster’s location in Australia…


DAVE & BUSTER’S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION

May 19 2026 - PR NewsWire

Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights First Dave & Buster’s location in Australia…


BenQ Delivers the Total Meeting Room Solution with the BenQ Board CP05 and InstaShow® WDC25

May 18 2026 - PR NewsWire

SYDNEY, May 18, 2026 /PRNewswire/ — BenQ Australia, today announced two new products that together deliver a complete, meeting room…


Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

May 16 2026 - PR NewsWire

RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date. Dr. Coulie brings…


Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial

May 15 2026 - PR NewsWire

Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced…


Analyse The Market From A Different Angle